Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.

about

Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.

Item

http://www.wikidata.org/entity/Q47327177

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@en

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@nl

type

Item

label

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@en

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@nl

prefLabel

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@en

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@nl

P1476

Terminating Migraine-Associate ...... ive Non-Randomized Drug Trial.

@en

P2093

Agustin Melo-Carrillo

http://www.w3.org/2001/XMLSchema#string

Catherine Buettner

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

The International Classification of Headache Disorders, 3rd edition (beta version)

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Neuronal plasticity: increasing the gain in pain

Method for quantitative estimation of thermal thresholds in patients.

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Glial activation: a driving force for pathological pain.

Central sensitization and LTP: do pain and memory share similar mechanisms?

Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.

P304

478-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEAD.13031

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rami Burstein

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28225188

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

diclofenac